Evidence map›Paper›PMID 33986644›Full record

ArticleFrontiers in molecular neuroscience2021

Editorial: P2X7 as Common Therapeutic Target in Brain Diseases.

Tobias Engel, Annette Nicke, Jan M Deussing, Beata Sperlagh, Miguel Diaz-Hernandez

Open access · goldAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Inter-Organellar CaCells · 2025
    Review
  2. Review
  3. Review
  4. P2X7 Variants in Pathophysiology.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 4 countries.

Tobias EngelDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland.
Annette NickeFaculty of Medicine, Walther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität München, Munich, Germany.
Jan M DeussingMolecular Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
Beata SperlaghLaboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, Hungary.
Miguel Diaz-HernandezDepartment of Biochemistry and Molecular Biology, Veterinary School, Complutense University of Madrid, Madrid, Spain.
HUN-REN Institute of Experimental Medicine · HULudwig-Maximilians-Universität München · DEMax Planck Institute of Psychiatry · DEScience Foundation Ireland · IEUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ATPbrain diseasesP2X7 receptorpurinergic signalingshared pathological pathways

Identifiers

PMID33986644
PMCPMC8110915
OpenAlexW3157881941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.